Patents Assigned to JJ Pharma, Inc.
  • Phenazine compounds and use thereof in autoimmune and inflammatory diseases
    Patent number: 8273881
    Abstract: The invention discloses compounds, compositions and methods useful for preventing and/or treating autoimmune diseases and inflammatory diseases. The methods and compositions utilize water-soluble phenazine compounds, or salts, or solvates thereof. These molecules can be delivered alone or in combination with agents which treat or prevent autoimmune diseases and inflammatory diseases such as those caused by arthritis and rheumatoid arthritis.
    Type: Grant
    Filed: January 16, 2008
    Date of Patent: September 25, 2012
    Assignee: JJ Pharma, Inc.
    Inventor: Josefino B. Tunac
  • PHENAZINE COMPOUNDS AND USE THEREOF IN AUTOIMMUNE AND INFLAMMATORY DISEASES
    Publication number: 20100190799
    Abstract: The invention discloses compounds, compositions and methods useful for preventing and/or treating autoimmune diseases and inflammatory diseases. The methods and compositions utilize water-soluble phenazine compounds, or salts, or solvates thereof. These molecules can be delivered alone or in combination with agents which treat or prevent autoimmune diseases and inflammatory diseases such as those caused by arthritis and rheumatoid arthritis.
    Type: Application
    Filed: January 16, 2008
    Publication date: July 29, 2010
    Applicant: JJ PHARMA, INC.
    Inventor: Josefino B. Tunac
  • Phenazine Compounds and Use Thereof in Autoimmune and Inflammatory Disease
    Publication number: 20080269231
    Abstract: The invention discloses compounds, compositions and methods useful for preventing and/or treating autoimmune diseases and inflammatory diseases. The methods and compositions utilize water-soluble phenazine compounds, or salts, or solvates thereof. These molecules can be delivered alone or in combination with agents which treat or prevent autoimmune diseases and inflammatory diseases such as those caused by arthritis and rheumatoid arthritis.
    Type: Application
    Filed: January 16, 2008
    Publication date: October 30, 2008
    Applicant: JJ Pharma, Inc.
    Inventor: Josefino B. Tunac
  • HDL-boosting combination therapy complexes
    Patent number: 7390504
    Abstract: A pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inhibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: June 24, 2008
    Assignee: JJ Pharma, Inc.
    Inventor: Josefino B. Tunac